| 000 | 01592 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517160241.0 | ||
| 264 | 0 | _c20180326 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-017-0400-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoisson, Bertrand | |
| 245 | 0 | 0 |
_aHuman IκBα Gain of Function: a Severe and Syndromic Immunodeficiency. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cJul 2017 |
||
| 300 |
_a397-412 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aGain of Function Mutation |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity _xgenetics |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xdiagnosis |
| 650 | 0 | 4 |
_aNF-KappaB Inhibitor alpha _xgenetics |
| 650 | 0 | 4 |
_aOrgan Specificity _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProteolysis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPuel, Anne | |
| 700 | 1 | _aPicard, Capucine | |
| 700 | 1 | _aCasanova, Jean-Laurent | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 37 _gno. 5 _gp. 397-412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-017-0400-z _zAvailable from publisher's website |
| 999 |
_c27260917 _d27260917 |
||